ANNAI JKKMRF”S SAMpooRANI AMMAl college oF phARMAcy- Komarapalayam
A survey study on therapeutic management of complication
Status in patient with diabetic mellitus in
rural areas of namakkal district
data collection form
Case no: Date:
Patient name: Age: sex: male / female
Height : weight: BP:
Type of diabetes mellitus: Type 1 Type 2 gestational
[Link]
Family history: disease
[Link]
Co-morbidity: [Link]
[Link]
Complication: [Link]
eye foot UTI KIDNEY NERVE Ear heart CNS
[Link]
[Link]
Diabetes mellitus theraphy:
Cost of therapy patient perception:
High low moderate
Adherence:
Missed dose Not correct time Self increasing dose No time to checkup
Refill:
before tablet over After tablet over More than 2 days over
Daily activity(exercise:walking): mild \ moderate.
Genetic disorder: Yes / No
ANNAI JKKMRF”S SAMpooRANI AMMAl college oF phARMAcy- Komarapalayam
Blood sugar tests:
FBS : [3.9 to 5.4 mmols/l] (70 to 99mg/dl)
RBS : [4.4-8.9 mmol/l](80-130mg/dl)
PPBS: [5-7.2mmol/l] (90-130mg/dl)
HBA1C:
Types of treatment:
[Link]: yes /no
[Link]: yes /no
[Link]: yes/no
Insulin administration: injection / pen
How many times you use insulin injection: OD/bd/tds
Insulin injection:
Rapid acting.
short-acting
long-acting
intermediate-acting
Oral drug:
1. sulfonylureas tolbutamide glibenclamide glipizide gliclazide glimepiride
2. Meglitidine/phenylalanine repaglinide Nateglinide
analogues
3. GLP-1(injectable drugs) Exenatide liraglutide
4. DPP4-4 inhibitors Sitagliptin Vildagliptin Algogliptin linagliptin Saxagliptin
Algogliptin
5. Biguanide(AMPk activator metformin PPARγ pioglitazone
activitaor
6. Glucosidase inhibitors acarbose miglitol voglibose
7. Amylin analogue Pramlintide
8. Dopamine D2 receptor bromocriptin
9. SGLT-2 inhibitor dapaglifloxine